Dr. Jonathan B. Strober , MD
Pediatrics • San Francisco, CA
400 Parnassus Ave Fl 8
San Francisco, CA 941432202
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 6, 2006; this date does not establish years in practice.
-
Published CMS data list 31 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50) — 18 prescription fills, including refills.
- Amondys-45 (Casimersen) — 13 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 70% of clinicians listed under Pediatrics in San Francisco, CA (2024, 15 clinicians with data). Median for this group: 128. Middle half: 26 to 296.
Fewer Part D prescriptions than 70% of clinicians listed under Pediatrics in California (2024, 233 clinicians with data). Median for this group: 108. Middle half: 27 to 557.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 24 in 2018 to 31 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2018–2024.
Practice Location & Contact Primary Location
400 Parnassus Ave Fl 8
San Francisco, CA 941432202
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Ucsf Medical Group Business Services. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Temple University School Of Medicine
1992
What Public CMS Data Show
Pediatrics: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
31 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,094,441 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $51,861.96 across 70 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $29,176.00 across 8 records.
- Consulting Fee: $16,018.00 across 9 records.
- Travel and Lodging: $3,553.69 across 28 records.
Reporting-company totals (3 largest of 8)
- Biogen, Inc.: $35,340.45 across 38 records.
- Janssen Pharmaceuticals, Inc: $9,949.94 across 13 records.
- Janssen Pharmaceuticals, Inc: $3,494.18 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
34 years (graduated 1992)
CMS Doctors and Clinicians data list 1992 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Strober has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Strober as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in San Francisco and California
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 70% of clinicians listed under Pediatrics in San Francisco, CA (2024, 15 clinicians with data). Median for this group: 128. Middle half: 26 to 296.
Fewer Part D prescriptions than 70% of clinicians listed under Pediatrics in California (2024, 233 clinicians with data). Median for this group: 108. Middle half: 27 to 557.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Pediatrics in San Francisco, CA (2024, 15 clinicians with data). Median for this group: $11,344. Middle half: $5,798 to $56,246.
A higher Part D drug cost than 95% of clinicians listed under Pediatrics in California (2024, 233 clinicians with data). Median for this group: $6,553. Middle half: $650 to $47,056.
513 active clinicians are listed under Pediatrics with a practice address in San Francisco, CA (9,320 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in San Francisco
2.1% of these 513 clinicians have the CMS telehealth indicator.
8.4% of these 513 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 29% from 24 in 2018 to 31 in 2024.
- 2018: 24
- 2019: 12
- 2020: 11
- 2022: 11
- 2024: 31
-
30-day fills
30-day fills increased 11% from 28 in 2018 to 31 in 2024.
- 2018: 28
- 2019: 12
- 2020: 11
- 2022: 11
- 2024: 31
-
Part D drug cost
Part D drug cost increased 66761% from $3,133 in 2018 to $2,094,441 in 2024.
- 2018: $3,133
- 2019: $5,992
- 2020: $1,656
- 2022: $1,892,105
- 2024: $2,094,441
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 390% from $10,586.59 in 2021 to $51,861.96 in 2025.
- 2021: $10,586.59
- 2022: $27,427.07
- 2023: $22,223.04
- 2024: $9,370.29
- 2025: $51,861.96
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 70 records totaling $51,861.96.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Biogen, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYCLARYS | General | $6,252.00 |
| Biogen, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYCLARYS | General | $6,252.00 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $5,550.00 |
| Biogen, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYCLARYS | General | $4,168.00 |
| Biogen, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYCLARYS | General | $3,647.00 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,330.00 |
| Biogen, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYCLARYS | General | $3,126.00 |
| Biogen, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,866.00 |
| Biogen, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYCLARYS | General | $2,605.00 |
| Biogen, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYCLARYS | General | $1,563.00 |
| Biogen, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYCLARYS | General | $1,563.00 |
| CATALYST PHARMACEUTICALS, INC. |
Honoraria
Cash or cash equivalent
|
AGAMREE | General | $1,200.00 |
| Janssen Research & Development, LLC |
Travel and Lodging
Cash or cash equivalent
|
— | General | $1,075.00 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $990.00 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $990.00 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $990.00 |
| Biogen, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $651.00 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
— | General | $593.91 |
| Biogen, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $521.00 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
— | General | $210.07 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
— | General | $181.26 |
| Biogen, Inc. |
Travel and Lodging
In-kind items and services
|
SKYCLARYS | General | $171.00 |
| Biogen, Inc. |
Travel and Lodging
In-kind items and services
|
SKYCLARYS | General | $168.00 |
| Biogen, Inc. |
Travel and Lodging
In-kind items and services
|
SKYCLARYS | General | $157.00 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
— | General | $148.99 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Hizentra | Immun Glob G(Igg)/Pro/Iga 0-50 | 18 | 504 | $70,779.77 | — |
| Amondys-45 | Casimersen | 13 | 364 | $2,023,660.80 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208000000X
A pediatrician is concerned with the physical, emotional and social health of children from birth to young adulthood. Care encompasses a broad spectrum of health services ranging from preventive healthcare to the diagnosis and treatment of acute and chronic diseases. A pediatrician deals with biological, social and environmental influences on the developing child, and with the impact of disease and dysfunction on development.
NUCC Taxonomy Code: 2084N0402X
A Child Neurologist specializes in neurology with special skills in diagnosis and treatment of neurologic disorders of the neonatal period, infancy, early childhood, and adolescence.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEUROLOGY
I20031216000812
CA
2062319205
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Ucsf Medical Group Business Services
3100 San Pablo Ave, Berkeley, CA 947022498
Phone: 5109855020
Ucsf Medical Group Business Services
400 Parnassus Ave, San Francisco, CA 941432202
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Pediatrics
Registered Nurse, Master of Science in Nursing
Pediatrics - Pediatric Transplant Hepatology
Doctor of Medicine (M.D.)
Pediatrics
Doctor of Medicine (M.D.)
Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology
Doctor of Medicine (M.D.)
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Physical Therapist
Doctor of Physical Therapy
Career & Practice History
NPI enumerated September 06, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Pediatrics Specialists in San Francisco
- Dr. Jaime Ruiz, MD
- Dr. Faustine Ramirez, MD
- Dr. Amy Gelfand, MD
- Dr. Anthony Portale, MD
- Dr. Robert Saken, MD
- Dr. Jennifer Cohen, MD
Mailing Address
1635 Divisadero St, Suite 625, Box 1821
San Francisco, CA 941430001
Phone: 4154764029